FPAS
KURA icon

Focus Partners Advisor Solutions’s Kura Oncology KURA Stock Holding History

Focus Partners Advisor Solutions’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127K Sell
15,565
-7,324
-32% -$62.9K ﹤0.01% 1190
2025
Q4 		$238K Buy
22,889
+1,682
+8% +$17.6K ﹤0.01% 963
2025
Q3 		$210K Buy
+21,207
New +$151K ﹤0.01% 1058

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Focus Partners Advisor Solutions's KURA Position: Q1 2026 in Review

Focus Partners Advisor Solutions reduced its Kura Oncology (KURA) stake by 32% in Q1 2026, selling an estimated $62.9K and leaving 15,565 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Focus Partners Advisor Solutions first reported a position in KURA in Q3 2025 and has held it in 3 quarters since. The position peaked at $238K in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Focus Partners Advisor Solutions held 15,565 shares of Kura Oncology worth $127K as of Q1 2026.
  • Focus Partners Advisor Solutions sold 7,324 Kura Oncology shares in Q1 2026, an estimated $62.9K.
  • Kura Oncology made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #1190 holding.
  • Focus Partners Advisor Solutions first reported a position in Kura Oncology in Q3 2025 and has held it in 3 quarters since.
  • Focus Partners Advisor Solutions's Kura Oncology position peaked at $238K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.